A gene-based analysis of variants in the serum/glucocorticoid regulated kinase (SGK) genes with blood pressure responses to sodium intake: The GenSalt Study by Li, Changwei et al.




A gene-based analysis of variants in the serum/
glucocorticoid regulated kinase (SGK) genes with
blood pressure responses to sodium intake: The
GenSalt Study
Changwei Li
Tulane University School of Public Health and Tropical Medicine
Xueli Yang
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
Jiang He
Tulane University School of Public Health and Tropical Medicine
James E. Hixson
University of Texas Health Science Center at Houston
Dongfeng Gu
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
See next page for additional authors
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Li, Changwei; Yang, Xueli; He, Jiang; Hixson, James E.; Gu, Dongfeng; Rao, Dabeeru C.; Shimmin, Lawrence C.; Huang, Jianfeng;
Gu, Charles C.; Chen, Jichun; Li, Jianxin; and Kelly, Tanika N., ,"A gene-based analysis of variants in the serum/glucocorticoid
regulated kinase (SGK) genes with blood pressure responses to sodium intake: The GenSalt Study." PLoS One.9,5. e98432. (2014).
http://digitalcommons.wustl.edu/open_access_pubs/3049
Authors
Changwei Li, Xueli Yang, Jiang He, James E. Hixson, Dongfeng Gu, Dabeeru C. Rao, Lawrence C. Shimmin,
Jianfeng Huang, Charles C. Gu, Jichun Chen, Jianxin Li, and Tanika N. Kelly
This open access publication is available at Digital Commons@Becker: http://digitalcommons.wustl.edu/open_access_pubs/3049
A Gene-Based Analysis of Variants in the Serum/
Glucocorticoid Regulated Kinase (SGK) Genes with Blood
Pressure Responses to Sodium Intake: The GenSalt Study
Changwei Li1., Xueli Yang2., Jiang He1,3, James E. Hixson4, Dongfeng Gu2, Dabeeru C. Rao5,
Lawrence C. Shimmin4, Jianfeng Huang2, Charles C. Gu5, Jichun Chen2, Jianxin Li2, Tanika N. Kelly1*
1Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America, 2 State Key Laboratory
of Cardiovascular Disease, Fuwai Hospital, National Center of Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing,
China, 3Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, United States of America, 4Department of Epidemiology, Human
Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, Texas, United States of America, 5Division of Biostatistics, Washington
University School of Medicine, St. Louis, Missouri, United States of America
Abstract
Background: Serum and glucocorticoid regulated kinase (SGK) plays a critical role in the regulation of renal sodium
transport. We examined the association between SGK genes and salt sensitivity of blood pressure (BP) using single-marker
and gene-based association analysis.
Methods: A 7-day low-sodium (51.3 mmol sodium/day) followed by a 7-day high-sodium intervention (307.8 mmol sodium/
day) was conducted among 1,906 Chinese participants. BP measurements were obtained at baseline and each intervention
using a random-zero sphygmomanometer. Additive associations between each SNP and salt-sensitivity phenotypes were
assessed using a mixed linear regression model to account for family dependencies. Gene-based analyses were conducted
using the truncated p-value method. The Bonferroni-method was used to adjust for multiple testing in all analyses.
Results: In single-marker association analyses, SGK1 marker rs2758151 was significantly associated with diastolic BP (DBP)
response to high-sodium intervention (P= 0.0010). DBP responses (95% confidence interval) to high-sodium intervention for
genotypes C/C, C/T, and T/T were 2.04 (1.57 to 2.52), 1.79 (1.42 to 2.16), and 0.85 (0.30 to 1.41) mmHg, respectively. Similar
trends were observed for SBP and MAP responses although not significant (P = 0.15 and 0.0026, respectively). In addition,
gene-based analyses demonstrated significant associations between SGK1 and SBP, DBP and MAP responses to high sodium
intervention (P = 0.0002, 0.0076, and 0.00001, respectively). Neither SGK2 nor SGK3 were associated with the salt-sensitivity
phenotypes in single-maker or gene-based analyses.
Conclusions: The current study identified association of the SGK1 gene and BP salt-sensitivity in the Han Chinese
population. Further studies are warranted to identify causal SGK1 gene variants.
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Introduction
High salt intake has been associated with an elevated risk of
high blood pressure (BP) and cardiovascular disease [1,2]. BP
responses to dietary sodium intake vary considerably among
individuals, a phenomenon described as salt sensitivity of BP [3].
Previous family studies have documented a moderate to high
heritability of salt sensitivity, generally ranging from 22% to 84%
[4–6]. Likewise, linkage analyses and genetic association studies
have suggested that genetic mechanisms may play a pivotal role in
BP salt sensitivity [7]. The identification of genetic variants for salt
sensitivity will help elucidate how genes interact with dietary
factors to influence the regulation of BP.
The serum and glucocorticoid regulated kinases (SGK) play
important roles in regulating Na+ transport in both proximal and
distal elements of the kidney tubule [8,9]. The SGK family of
protein kinases have three isoforms, SGK1, SGK2 and SGK3 [9].
All of the three isoforms are highly expressed in kidney [10–12].
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SGK1 stimulates the epithelial Na+ channel (ENaC), Na+/H+
exchanger 3 (NHE3) and many other renal tubular ion channels to
regulate renal Na+ reabsorption [9,13,14]. SGK1 also contributes
to the stimulation of mineralocorticoid-induced salt intake [14].
Recent studies showed increased salt concentration induces SGK1
expression, and increased SGK1 subsequently enhances TH17 cell
differentiation and promotes tissue inflammation [15]. These
findings support the opinion that the intensity of immune cell
infiltration in the kidney is correlated with the severity of salt-
sensitive hypertension [16]. Thus the effect of SGK1 on sodium
homeostasis and inflammation is expected to have an important
impact on blood pressure control. Similar to SGK1, both SGK2
and SGK3 can influence NHE3 activities and potentially regulate
Na+ transport [9]. SGK’s biological relevance combined with
evidence in vitro and in vivo make the genes encoding SGK
interesting candidates for genetic study of BP response to sodium
intake. However, only a few studies have reported associations of
variants in the SGK gene family with BP phenotypes in human
samples [17–19]. None have investigated the joint effect of
multiple variants within single genes, and none of them were
conducted in the Chinese population. The aim of the current study
was to assess the single and joint effects of genetic variants in SGK
genes with BP salt sensitivity among Han Chinese participants of




The GenSalt study is a unique dietary feeding study examining
gene-dietary sodium and potassium interaction on blood pressure
among a rural Han population in north China with habitual high
salt intake. Probands were defined as having mean SBP between
130 and 160 mm Hg and/or mean DBP between 85 and 100 mm
Hg and no use of antihypertension medications. The probands
were identified through a community-based BP screening carried
out among adults aged 18–60 years in the study villages. Probands
along with their spouses, siblings, and offspring were recruited as
volunteers for the dietary intervention study. Detailed eligibility
criteria for the probands and siblings/spouses/offspring have been
presented elsewhere [20]. Briefly, individuals with stage-2 hyper-
tension ($160/100 mmHg), current or recent use of antihyper-
tension medications, secondary hypertension, history of clinical
CVD, diabetes, chronic kidney failure, liver disease or peptic ulcer
disease requiring treatment during the previous two years, along
with pregnant women, heavy alcohol drinkers, and those currently
adhering to a low-sodium diet or unable to sign the informed
consent were excluded from the study. The study recruited 1,906
eligible participants from 633 families. A total of 1,871 (98.2%)
and 1,860 (97.6%) participants who completed the low-sodium
and high-sodium dietary interventions, respectively, were included
in the current analysis.
Ethnics Statement
Institutional review boards at the Tulane University Health
Sciences Center, Washington University School of Medicine,
University of Texas School of Public Health, Fu Wai Hospital and
Chinese National Human Genome Center at Beijing, and Chinese
Academy of Medical Sciences approved the GenSalt study.
Written informed consents for the baseline observation and for
the intervention program were obtained from each participant.
Dietary Intervention
After a 3 day baseline examination period, the study partici-
pants underwent a 7 day low-sodium dietary intervention (51.3-
mmol of sodium/day) followed by a 7 day high-sodium dietary
intervention (307.8-mmol of sodium/day). Dietary potassium
intake remained unchanged during the intervention phases. Total
energy intake was varied according to each participant’s baseline
energy intake. All study foods were cooked without salt, and pre-
packaged salt was added to the individual study participant’s meal
when it was served by the study staff. To ensure compliance with
the intervention program, participants were required to have their
breakfast, lunch and dinner in the study kitchen under the
supervision of the study staff during the entire intervention period.
The study participants were also instructed to avoid consuming
any foods that were not provided by study personnel. Three timed
urinary specimens were collected at baseline and at the end of
each intervention phase (days 5, 6 and 7) to monitor the
compliance with the intervention. The results of 24-hour urinary
excretion of sodium showed excellent compliance with the study
diet among all participants. The respective mean (SD) of 24-hour
urinary excretions at baseline, during the low-sodium intervention,
and during the high-sodium intervention were 242.4 (66.7), 47.5
(16.0) and 244.3 (37.7) mmol for sodium, and 36.9 (9.6), 31.4 (7.7),
and 35.7 (7.5) mmol for potassium.
Phenotype Measurement
During the 3 days baseline examination, trained staff collected
information on family structure, demographic characteristics,
personal and family medical history, and lifestyle risk factors
using a standard questionnaire. BP was measured 3 times at the
same time each morning during the 3-day baseline and days 5, 6,
and 7 during each intervention period according to a standard
protocol. All BP was measured by trained and certified observers
using a random zero sphygmomanometer with the participants in
the sitting position after resting for 5 minutes [21]. Participants
were advised to avoid alcohol, cigarette smoking, coffee/tea, and
exercise for at least 30 minutes before the BP measurements. All
BP observers were unaware of the dietary intervention stages. In
addition, body weight and height were measured twice during the
baseline examination with the participants in light indoor clothing
without shoes. Body mass index (BMI) was calculated as kilograms
per meters squared.
Salt sensitivity phenotypes were defined as the absolute changes
in SBP, DBP, and MAP from baseline to low-sodium intervention
and from low-sodium intervention to high-sodium intervention.
The means of 9 BP measures at baseline and on days 5, 6, and 7 of
each intervention stage were calculated. Mean BP responses to
low-sodium intake were calculated as the mean BP measures
during low-sodium intervention minus the mean BP at baseline,
and mean BP responses to high-sodium intake as mean BP during
high-sodium intervention minus that during low-sodium interven-
tion.
Single Nucleotide Polymorphism (SNP) Genotyping of
SGK Genes
SNPs located within the SGK genes and their 65,000 base-pair
flanking regions were genotyped among all participants using chip
based hybridization assays (Affymetrix 6.0, Santa Clara, CA).
SNPs were excluded if they had a call rate less than 95%, were not
in Hardy-Weinberg Equilibrium after adjustment for multiple
comparisons (Bonferroni correction), or had a minor allele
frequency (MAF) less than 1%. MapMaker/Sibs and PedCheck
were used to check for Mendelian inconsistencies within families
SGK Gene and Blood Pressure Salt-Sensitivity
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for each marker. Among the 71 SNPs within SGK genes, 56 met
the quality control criteria, and 39 were tagged (r2,0.9) using
Haploview software for inclusion in the current analysis [22].
Detailed information about the SGK genes and the 39 SNPs
including their genomic locations, MAFs, call rates and P values
for HWE tests are presented in Table 1 and Table S1.
Statistical Analysis
The means or percent of baseline characteristics and BP
response variables were calculated for all participants. Additive
associations between single SNPs and BP responses to each sodium
intervention were assessed using a mixed linear regression model
to account for familial correlations. Age, gender, field center, and
BMI were controlled in all the association analyses. To correct for
multiple testing with the 39 variants, the Bonferroni method was
used (a-threshold = 0.05/39 = 1.2861023). For significant SNPs,
we estimated the mean BP responses and 95% confidence interval
(CI) for each genotype using a mixed linear regression model. The
association analyses were conducted using SAS software (version
9.2; SAS Institute, Inc., Cary, North Carolina).
The joint effect of variants in the SGK genes on BP responses to
sodium intervention was evaluated by combining P values from
single SNP association analyses using the truncated product
method (TPM) [23,24]. Truncation point was set as t= 0.10, and
the P value for TPM was estimated by 10,000 simulations. If
10,000 simulations failed to generate a P value, simulations were
increased up to 1,000,000. Sensitivity analyses were conducted
using TPM after excluding significant SNPs within a gene to
examine their influence on the gene-based analysis. Bonferroni
correction was applied to account for multiple testing with 3 genes
(a-threshold = 0.05/3 = 0.017). Gene-based analysis was per-
formed using R software (Version 2.15.2; http://www.r-project.
org).
Results
The GenSalt participant’s baseline characteristics and BP
responses to sodium interventions are shown in Table 2. Blood
pressure significantly decreased in response to the low-sodium
dietary intervention and increased in response to the high-sodium
dietary intervention (all P,0.0001). In response to the low-sodium
intervention, decreases of 5.5 mmHg, 2.8 mmHg, and 3.7 mmHg
were observed for SBP, DBP and MAP, respectively. SBP, DBP
and MAP increased 4.9 mmHg, 1.9 mmHg, and 2.9 mmHg,
respectively, in response to high-sodium intervention.
The single-marker association analyses are shown in Figure 1.
SNP, rs2758151, which is located 2.7 kbp downstream to the
SGK1 gene, was significantly associated with absolute DBP
responses to high-sodium intervention (P= 0.001). As shown in
Figure 2, DBP responses to high-sodium intervention decreased
with the number of minor T alleles of rs2758151. Mean DBP
response was 2.04 (1.57 to 2.52) mmHg for participants with CC
genotype (n = 510), 1.79 (1.42 to 2.16) mmHg for those with CT
genotype (n = 911), and 0.85 (0.30 to 1.41) mmHg for those with
TT genotype (n = 415). Similar trends were observed for SBP and
MAP response to the high sodium interventions (P= 0.146 and
0.003, respectively). Exact P values for all single SNP association
tests are shown in Table S2.
Table 3 shows the results of the gene-based analyses. SGK1 was
significantly associated with SBP, DBP and MAP responses to
high-sodium intervention. In sensitivity analyses excluding signif-
icant SGK1 marker rs2758151, all statistically significant SGK1
results remained significant with the exception of DBP response to
high-sodium. P-values for the association between SGK1 and SBP,
DBP, and MAP responses in the sensitivity analysis were
9.061025, 0.09 and 5.261024, respectively.
Discussion
In the first study to examine the association between the SGK
gene pathway and salt-sensitivity of BP in an East Asian
population, we identified a significant association between SGK1
variant rs2758151 and DBP response to high-sodium intervention.
Each copy of the rs27858151 minor T allele predicted smaller
DBP responses to the high-sodium diet. Similar trends were
observed for the SBP and MAP responses to high sodium
phenotypes although not significant. In addition, gene-based
analysis revealed that the SGK1 gene was significantly associated
Table 1. Characteristics of SGK1, SGK2 and SGK3 genes.
Gene





SGK1 serum/glucocorticoid regulated kinase 1 6q23 (134485384,
134644196)
29 Contributes to Na+ retention and K+
elimination of the kidney.
SGK2 serum/glucocorticoid regulated kinase 2 20q13.2 (42182635,
42219273)
8 Encodes a serine/threonine protein kinase.




2 Involved in neutral amino acid transport and
activation of potassium and chloride channels.
Chr, chromosome; SNP, single-nucleotide polymorphism.
doi:10.1371/journal.pone.0098432.t001
Figure 1. –log10 P values for the associations of 39 SNPs in
SGK1, SGK2 and SGK3 with blood pressure responses to low-
sodium intervention (a) and high-sodium intervention (b).
Labeled SNP was significant after Bonferroni correction. The horizontal
dashed lines indicate the Bonferroni corrected significant level.
doi:10.1371/journal.pone.0098432.g001
SGK Gene and Blood Pressure Salt-Sensitivity
PLOS ONE | www.plosone.org 3 May 2014 | Volume 9 | Issue 5 | e98432
with all BP responses to the high-sodium intervention. While it
appeared that the gene-based association of the DBP response
phenotype could be explained by significant marker rs27858151,
the SBP and MAP response phenotypes remained significant after
sensitivity analyses excluding this SNP. Neither the gene-based nor
single-marker analyses identified significant association of the
SGK2 and SGK3 genes with the BP response phenotypes. To the
best of our knowledge, this is the first study examining the joint
effect of SNPs in genes of the SGK family on the blood pressure
salt-sensitivity phenotype. In aggregate, these findings could
provide valuable information towards delineating the genomic
mechanisms underlying human BP salt-sensitivity.
SGK1 variant rs2758151 showed evidence of association with BP
salt-sensitivity in the current analysis. It is of interest to note that
Figure 2. Blood pressure responses to high sodium intervention among participants with different genotypes of rs2758151,
respectively. *significant after Bonferroni correction.
doi:10.1371/journal.pone.0098432.g002
SGK Gene and Blood Pressure Salt-Sensitivity
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this variant was implicated in the only other candidate gene study
to examine the relationship between SGK1 and BP salt-sensitivity
to date [17]. In the previous report, Rao and colleagues identified
a significant association between rs2758151 and BP response to
high sodium intervention in a population of European ancestry
[17]. However, their study reported an opposite effect direction of
the T allele [17]. A potential reason for this discrepancy could be
that rs2758151 is not the causal locus for the salt-sensitivity
phenotype but is in linkage disequilibrium (LD) with the causal
variant [25]. The causal variant may be on different haplotypes in
populations of distinct ethnicities. In support of this hypothesis,
post-hoc comparison of LD patterns between European and
Chinese populations at the SGK1 locus showed distinct differences
in LD structure between these populations (P= 0.01 for differences
in LD pattern; see Figure S1) [26,27]. In addition, differences in
direction of association could be due to interactive effects with
other variants or environmental factors that vary between
populations [28]. Lin et al used theoretical modeling to demon-
strate that such ‘‘flip-flop’’ associations may indeed represent
confirmations of true associations due to interactive effects or LD
with a causal variant at another locus [29]. Marker rs2758151 is
located downstream of the SGK1 gene and is unlikely to play a
causal role in altering the synthesis or structure of the SGK1
protein. Future studies will be needed to pinpoint the true
functional variant responsible for the strong signal reported by
both us and Rao et al. Such work could leverage LD information
in East Asians and Caucasians to help localize the region for
sequencing study.
Our study also represents the first report of gene-based
associations of SGK1 and BP salt-sensitivity phenotypes. We
identified significant associations of SGK1 with SBP, DBP and
MAP responses to high-sodium intervention. Although sensitivity
analyses revealed that the association between SGK1 and DBP
response was largely driven by marker rs2758151, this variant
could not explain the gene-based relation of SGK1 with both SBP
and MAP responses to the high-sodium dietary intervention. Such
Table 2. Characteristics of 1,906 GenSalt dietary intervention participants.
Variables Mean SD or percentage Median (interquartile range)
Age 38.769.6 39.0 (33.0 to 46.0)
Men, % 53.0
BMI, kg/m2 23.363.2 22.9 (21.1 to 25.2)
Creatinine level at baseline, mg/dL 0.9 (0.2) 0.9 (0.8 to 1.1)
Baseline blood pressure
SBP 116.9614.2 115.8 (106.4 to 127.1)
DBP 73.7610.3 73.3 (66.7 to 80.7)
MAP 88.1610.9 87.7 (80.1 to 95.4)
Response to low sodium intervention
SBP, mm Hg 25.567.0* 24.4 (28.9 to 21.3)
DBP, mm Hg 22.865.5* 22.7 (25.6 to 0.4)
MAP, mm Hg 23.765.3* 23.3 (26.6 to 20.6)
Response to high sodium intervention
SBP, mm Hg 4.966.0* 4.4 (0.6 to 8.2)
DBP, mm Hg 1.965.4* 1.8 (21.6 to 5.3)
MAP, mm Hg 2.965.0* 2.7 (20.4 to 5.9)
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure;
*P,0.0001 when comparing blood pressure change with 0.
doi:10.1371/journal.pone.0098432.t002
Table 3. Gene-based associations of SGK1, SGK2 and SGK3 with blood pressure responses to dietary sodium intervention.
SGK1 SGK2 SGK3
Response to low-sodium intervention
SBP 0.1541 0.1037 0.1708
DBP 0.6240 0.3212 0.1326
MAP 0.2474 0.2589 0.1505
Response to high-sodium intervention
SBP 0.0002* 0.0422 0.2008
DBP 0.0076* 0.2669 0.1388
MAP 1.00E-05* 0.1822 0.1309
BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure;
*Significant P values after Bonferroni correction.
doi:10.1371/journal.pone.0098432.t003
SGK Gene and Blood Pressure Salt-Sensitivity
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findings indicate that there might be multiple independent loci
within SGK1 that are related to these phenotypes. Furthermore,
our findings highlight the importance of considering both singular
and joint effects of variants to elucidate the genetic architecture of
complex phenotypes like BP response to dietary sodium interven-
tion.
SGK2 and SGK3 were not associated with BP salt-sensitivity in
the current analysis, nor were any single variants within the two
genes. Although very few studies have been conducted to examine
the association of the SGK2 and SGK3 genes with BP phenotypes
[8,30], our results are consistent with animal models. For example,
Schnackenberg and colleagues showed that SGK2 knockout mice
did not exhibit urinary Na+ wasting or low blood pressure [31].
Similarly, SGK3 knockout mice were not found to have obvious
defects in Na+ handling in a manuscript by McCormick and
collagues [32].
Our study has several important strengths. GenSalt is the largest
dietary intervention study to examine the associations between the
SGK gene pathway and BP responses to dietary sodium
intervention. A high proportion of study participants completed
the dietary intervention (97.6%), and compliance with the study
interventions was excellent, as confirmed by urinary excretion of
sodium and potassium during each intervention period. Measure-
ment error was reduced and power enhanced by the large number
of BP measures that were collected for each participant.
Furthermore, stringent quality control methods were used in
measuring BP and other study covariables, genotyping, and
marker data cleaning. Finally, the recruitment of only Han
Chinese participants should make the analysis robust to even fine
levels of population stratification. Although the Affymetrix 6.0
platform generally provides good genomic coverage of common
variants in the Han Chinese population [33], coverage of SGK3
was limited, with only two tag SNPs in the SGK3 gene. Therefore,
common SGK3 variants associated with BP salt-sensitivity may
have been missed by the current study. Further, the gene-based
analysis for SGK3 must be interpreted with caution. Finally, due to
the uniqueness of salt-sensitivity phenotype, our findings could not
be replicated in an independent East Asian sample.
The current study identified a significant association of SGK1
marker rs2758151 with BP salt-sensitivity. Having previously been
reported to associate with BP responses to dietary sodium in a
population of European ancestry, these findings provide some
evidence of trans-ethnic replication in the Han Chinese popula-
tion. Furthermore, our gene-based analysis revealed potentially
important joint actions of SGK1 SNPs on the salt-sensitivity
phenotypes. These findings contribute important information
towards elucidating the genomic mechanisms underlying blood
pressure regulation. Still, further studies will be necessary to
localize the reported SGK1 signals and identify the causal variants




Table S1 Quality control information of the tagged 39
SNPs in SGK1, SGK2 and SGK3.
(DOC)
Table S2 P-Values of single SNP association analysis of
the 39 SNPs in SGK1, SGK2 and SGK3 with blood
pressure responses to dietary sodium intervention.
(DOCX)
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